Next 10 |
home / stock / pxmvf / pxmvf news
Pixium Vision announces the rejection of the sale plan ( plan de cession ) by the Court and the conversion of the receivership proceedings into liquidation proceedings Paris, France, February 2, 202 4 – 02:00 p.m. (CET) – Pixium Vision SA (Eu...
Postponement of the decision on the adoption of a sale plan ( plan de cession ) and the opening of judicial liquidation proceedings to January 31, 2024 Paris, France, January 17, 202 4 – 5:00 pm (CET) – Pixium Vision SA (Euronext Growth Paris...
Postponement of the decision on the adoption of a sale plan ( plan de cession ) and the opening of judicial liquidation proceedings Paris, France, January 17, 202 4 – 7:00 am (CET) – Pixium Vision SA (Euronext Growth Paris - FR001400JX97; Mne...
Decision concerning the adoption of a sale plan ( plan de cession ) and the opening of judicial liquidation proceedings scheduled for January 16, 2024 Paris, France, December 18, 202 3 – 7:00 pm (CET) – Pixium Vision SA (Euronext Growth Paris...
Commercial Court hearing to examine the takeover offer scheduled for December 18, 2023 Paris, France, December 4, 202 3 – 7:00 am (CET) – Pixium Vision SA (Euronext Growth Paris - FR001400JX97; Mnemo: ALPIX), a bioelectronics company developing innovativ...
Update on the receivership proceedings: submission of a takeover offer to the court-appointed administrators Paris, France, November 20, 202 3 – 5:45 pm (CET) – Pixium Vision SA (Euronext Growth Paris - FR001400JX97; Mnemo: ALPIX), a bioelectronics compa...
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD Study confirms subretinal prothesis feasible and well-tolerated with no reduction of natural peripheral vision, confirming 36-month results Patients suffering from central vision loss reliably re...
Pixium Vision announces the conversion of the safeguard proceedings into receivership Paris, France, November 13, 202 3 – 8:00 pm (CET ) – Pixium Vision SA (Euronext Growth Paris - FR001400JX97; Mnemo: ALPIX), a bioelectronics company developing inn...
2023-10-26 09:16:00 ET More on Pixium Vision SA Historical earnings data for Pixium Vision SA Financial information for Pixium Vision SA For further details see: Pixium Vision SA GAAP EPS of -€0.07, revenue of €0.9M
Pixium Vision announces its financial results for H1 2023 and provides update Post period event: Received shareholder loan of €3 million from BPIFrance and Sofinnova. Extension of the maturity of outstanding notes €1.25 million, Implemented a reverse stock split, exchanging ...
News, Short Squeeze, Breakout and More Instantly...
Pixium Vision Company Name:
PXMVF Stock Symbol:
OTCMKTS Market:
Pixium Vision announces the rejection of the sale plan ( plan de cession ) by the Court and the conversion of the receivership proceedings into liquidation proceedings Paris, France, February 2, 202 4 – 02:00 p.m. (CET) – Pixium Vision SA (Eu...
Postponement of the decision on the adoption of a sale plan ( plan de cession ) and the opening of judicial liquidation proceedings to January 31, 2024 Paris, France, January 17, 202 4 – 5:00 pm (CET) – Pixium Vision SA (Euronext Growth Paris...
Postponement of the decision on the adoption of a sale plan ( plan de cession ) and the opening of judicial liquidation proceedings Paris, France, January 17, 202 4 – 7:00 am (CET) – Pixium Vision SA (Euronext Growth Paris - FR001400JX97; Mne...